< Radiation Oncology < Bladder

Bladder: RTOG OPEN TRIALS
NumberTitle
09-26A Phase II Protocol For Patients With Stage T1 Bladder Cancer To Evaluate Selective Bladder Preserving Treatment By Radiation Therapy Concurrent With Cisplatin Chemotherapy Following a Thorough Transurethral Surgical Re-Staging
07-12A Phase II Randomized Study For Patients With Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery And Concomitant Chemoradiation By Either BID Irradiation Plus 5-Fluorouracil And Cisplatin Or QD Irradiation Plus Gemcitabine Followed By Selective Bladder Preservation And Gemcitabine/Cisplatin Adjuvant Chemotherapy
05-24A Phase I/II Trial Of A Combination Of Paclitaxel And Trastuzumab With Daily Irradiation Or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery For Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer


Bladder: RTOG CLOSED TRIALS
NumberTitlePublication
02-33A Phase II Randomized Trial For Patients With Muscle-Invading Bladder Cancer Evaluating Transurethral Surgery And BID Irradiation Plus Either Paclitaxel And Cisplatin Or 5-Fluorouracil And Cisplatin Followed By Selective Bladder Preservation And Gemcitabine/Paclitaxel/Cisplatin Adjuvant Chemotherapy 
99-06A Phase I/II Trial In Patients With Muscle-Invading Bladder Cancer Of Transurethral Surgery Plus Taxol, Cisplatin, And BID Irradiation Followed By Either Selective Bladder Preservation Or Radical Cystectomy And Adjuvant ChemotherapyPMID 19100600
97-06A Phase I/II Trial In Operable Patients With Muscle-Invading Bladder Cancer Of Transurethral Surgery And Cisplatinum/ BID Irradiation Followed by Either Selective Bladder Preservation Or Radical Cystectomy And Adjuvant ChemotherapyPMID 14529770
95-06A Phase I/II Trial Of Transurethral Surgery Plus Induction Chemoradiotherapy Followed By Either Selective Bladder Preservation Or Radical Cystectomy As Determined By Initial Response And Operability In Patients With Muscle-Invading Bladder CancerPMID 11110598
91-16Pilot Study of the Quality of Life of Bladder Cancer Patients Being Treated on the Companion Protocol RTOG-8903 
89-03A Phase III Trial To Study The Role of Neoadjuvant MCV Chemotherapy Combined With Transurethral Surgery Plus Cisplatin With Radiation Therapy For Selective Bladder Preservation In Patients With Muscle-Invading Bladder CancerPMID 9817278
88-14Phase I/II Study of Neoadjuvant Chemotherapy with MCV (MTX/CDDP/VBL) with Intraoperative Electron Beam Radiotherapy and Pre- and Postoperative External Beam Radiotherapy in Patients with Invasive Bladder Carcinoma 
88-02Phase I/II Study of Neoadjuvant Combined Modality Treatment with Chemotherapy with MCV (MTX/DDP/VBL) plus Radiotherapy and DDP with Selective Bladder Preservation in Patients with Invasive Bladder CancerPMID 8558186
87-05Phase I/II Study of Radiotherapy and Hyperthermia in Patients with Selected Measurable Superficial TumorsPMID 8256760
87-03Phase I/II Study of Combined Modality Therapy with DDP and Regional Hyperthermia in Patients with Malignancies of the Pelvis and Lower Abdomen 
86-08Phase II Trial of WR-2721 Administered Before Protracted Fractionated Radiotherapy in Patients with Cancer of the Rectum, Cervix, or Bladder 
85-12Phase II Study of Radiotherapy plus Chemotherapy with cis-Platinum for Stage B/C/D1 Carcinoma of the Bladder with Surgery for Treatment FailuresPMID 8478228
83-08Phase I/II Evaluation of Twice-Daily Fractional Radiotherapy for Locally Advanced Stage B/C/D Transitional Cell and Unresectable Squamous Cell Carcinoma of the BladderPMID 3058657
81-10Phase III Photon vs Mixed Beam Preoperative Radiotherapy for Stage B/C/D Carcinoma of the Bladder 
81-06Phase III Randomized Comparison of Sandwich vs Standard Preoperative Adjuvant Radiotherapy in Stage B/C Bladder Cancer 
81-05Phase I/II Misonidazole and Radiotherapy for Inoperable Bladder Cancer 
78-26Photon Radiotherapy vs Pion Radiotherapy for Transitional Cell Carcinoma of the Urinary Bladder 
78-21Phase I/II Radiosensitization with Misonidazole plus Radiotherapy for Bladder CancerPMID 7180834
78-17Phase II Study of Misonidazole plus Intraoperative Radiotherapy for Nonresectable Carcinomas 
78-16Phase I-II Hyperthermia (43.5 Degrees Centigrade) Before and After Radiation Treatment for Human Tumors 
78-04Adjuvant Radiotherapy before and after Surgery for Bladder CancerPMID 3967204
77-05Radiotherapy with Neutrons Alone or with Photons with or without Surgery for Urinary Bladder CancerPMID 6375854
76-12Preoperative or Postoperative Radiotherapy or Radiotherapy Alone for Clinical Stage B1 or B2 or C Bladder Carcinoma 
71-04Comparison of Split-Course versus Continuous Radiotherapy for Carcinoma of the Head and Neck and Urogenital RegionsPMID 4050737
This article is issued from Wikibooks. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.